Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia Areata affects people of all ages worldwide, is likely caused by genetic and environmental factors, and can lead to stress and depression, highlighting the need for treatments that address both physical and mental health.

The medicine baricitinib was found to notably improve hair regrowth in alopecia areata, but more research is needed on its side effects and other treatments.

Alopecia areata significantly impacts patients' mental health and quality of life.

Tofacitinib helped regrow hair in patients with alopecia, with few side effects.

New oral treatments for adult hair loss show promise, especially JAK inhibitors, with mild side effects.

Dupilumab may help treat alopecia areata in children with atopic dermatitis, but it can also cause new hair loss.

Tofacitinib may help treat both alopecia areata and inflammatory bowel disease.

Younger patients and those with more hair loss are less likely to benefit from oral steroid treatment for hair loss, and low vitamin D may predict relapse.

Tofacitinib is effective and safe for treating alopecia areata.

Excimer light therapy is more effective than low level laser therapy for treating alopecia areata.

Continuous treatment with ritlecitinib and brepocitinib is needed to maintain hair regrowth in alopecia areata.

Tofacitinib can regrow hair in alopecia areata patients, but some may experience flares during treatment.

High CCL11 levels may indicate poor response to baricitinib in severe alopecia areata.

Compound glycyrrhizin with conventional treatments is effective and safe for hair regrowth in alopecia areata.

Baricitinib effectively promotes regrowth of eyebrows and eyelashes in alopecia areata patients.

Baricitinib is effective for treating severe alopecia areata in Japanese patients, but long-term safety needs more study.

Adipose tissue-derived exosomes may help regrow hair in alopecia areata.

PRP is more effective than Minoxidil for treating alopecia areata.

Tofacitinib is a promising and safe treatment for moderate to severe alopecia areata.

Upadacitinib significantly improved both rheumatoid arthritis and alopecia areata in a patient.

Standard intralesional corticosteroids are the best treatment for patchy alopecia areata.

Alopecia Areata affects both patients and their cohabitants' quality of life and emotional well-being.

Baricitinib was effective in treating a patient with dermatomyositis and hair loss.

Certain genes may be linked to autoimmune conditions in people with alopecia areata.

Off-label treatments are heavily used for alopecia areata due to limited approved options.

Atopic dermatitis and alopecia areata share immune and genetic factors, and targeted therapies may help both.

Baricitinib effectively promotes hair regrowth in alopecia areata patients with mild side effects.

New treatments for alopecia areata show promise, but more research is needed to confirm their effectiveness.

Combining microneedling with triamcinolone acetonide is more effective for treating alopecia areata than microneedling alone.

Major depression disorder increases the risk of alopecia areata, and vice versa.